ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

LEGN Legend Biotech Corporation

45,26
-0,15 (-0,33%)
07 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Legend Biotech Corporation LEGN NASDAQ Depository Receipt
  Änderung Änderung % Aktuell Zeit
-0,15 -0,33% 45,26 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
45,41 44,7201 45,525 45,26 45,41
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
22.4.202419:05BWCARVYKTI® (ciltacabtagene autoleucel) Approved by the..
11.4.202414:00BWLegend Biotech to Host Investor Conference Call on First..
06.4.202405:30BWLegend Biotech’s CARVYKTI® (ciltacabtagene autoleucel)..
19.3.202413:30BWLegend Biotech Announces Publication of Inaugural..
15.3.202420:15BWCARVYKTI® (ciltacabtagene autoleucel) Receives..
11.3.202412:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11.3.202412:00BWLegend Biotech Reports Fourth Quarter and Full Year 2023..
11.3.202411:39IHMARKETNEWSU.S. Index Futures Dip Ahead of Inflation Data and Oracle’s..
29.2.202400:46EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
28.2.202401:47EDGAR2Form 144 - Report of proposed sale of securities
23.2.202419:10EDGAR2Form 144 - Report of proposed sale of securities
23.2.202413:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23.2.202413:15BWLegend Biotech Announces Positive CHMP Opinion for CARVYKTI®..
15.2.202402:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202414:00BWLegend Biotech to Host Investor Conference Call on Fourth..
23.1.202415:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23.1.202413:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09.1.202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03.1.202417:28BWLegend Biotech Announces Closing of License Transaction for..
03.1.202414:30BWLegend Biotech Announces Closing of License Transaction for..
02.1.202414:30BWLegend Biotech to Participate in the 42nd Annual J.P. Morgan..
27.12.202316:00EDGAR2Form 144 - Report of proposed sale of securities
22.12.202321:38EDGAR2Form 144 - Report of proposed sale of securities
22.12.202321:21EDGAR2Form 144 - Report of proposed sale of securities
21.12.202323:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21.12.202322:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12.12.202320:31EDGAR2Form 144 - Report of proposed sale of securities
12.12.202301:30BWPatient-Reported Outcomes from the CARTITUDE-4 Study Showed..
20.11.202312:25IHMARKETNEWSMonday’s Wall Street Highlights: GM, Microsoft, Citigroup,..
20.11.202312:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20.11.202312:00BWLegend Biotech Reports Third Quarter 2023 Results and Recent..
13.11.202315:16DJNLegend Biotech Subsidiary in License Agreement With Novartis
13.11.202314:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13.11.202314:30BWLegend Biotech Announces Exclusive, Global License Agreement..
07.11.202314:30BWLegend Biotech to Host Investor Conference Call on..
02.11.202314:17BWLegend Biotech to Showcase Leadership in Multiple Myeloma..
17.10.202323:39EDGAR2Form 144 - Report of proposed sale of securities
17.10.202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16.10.202323:20EDGAR2Form 144 - Report of proposed sale of securities
27.9.202318:02EDGAR2Form 144 - Report of proposed sale of securities
25.9.202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22.9.202322:20EDGAR2Form 144 - Report of proposed sale of securities
22.9.202322:10EDGAR2Form 144 - Report of proposed sale of securities
18.9.202322:41EDGAR2Form 144 - Report of proposed sale of securities
28.8.202316:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21.8.202322:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15.8.202312:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15.8.202312:00BWLegend Biotech Reports Second Quarter 2023 Results and..
03.8.202314:30BWLegend Biotech to Host Investor Conference Call on..
20.7.202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock